Free tool
FAERS Monitor: Matulane
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 016785 or its brand name (Matulane, Procarbazine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
4,792
Serious
1,270
27% of reports
Hospitalization
593
Death reported
323
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea1,054
- fatigue934
- vomiting327
- constipation296
- platelet count decreased257
- white blood cell count decreased244
- headache198
- decreased appetite194
- rash173
- diarrhoea147
- neutropenia147
- blood count abnormal132
- thrombocytopenia125
- dizziness119
- urticaria113
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 7 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 7 |
| 2008 | 5 |
| 2009 | 5 |
| 2010 | 45 |
| 2011 | 136 |
| 2012 | 250 |
| 2013 | 71 |
| 2014 | 55 |
| 2015 | 201 |
| 2016 | 245 |
| 2017 | 592 |
| 2018 | 555 |
| 2019 | 348 |
| 2020 | 318 |
| 2021 | 233 |
| 2022 | 355 |
| 2023 | 344 |
| 2024 | 358 |
| 2025 | 345 |
| 2026 | 311 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,367 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| blood count abnormalSignal | 132 | 38.5 | 32.6 | 4,752 |
| platelet count decreasedSignal | 257 | 10.6 | 9.4 | 2,232 |
| white blood cell count decreasedSignal | 244 | 9.9 | 8.8 | 1,949 |
| constipationSignal | 296 | 6.0 | 5.3 | 1,229 |
| nauseaSignal | 1,054 | 5.9 | 5.5 | 4,395 |
| fatigueSignal | 934 | 5.3 | 5.0 | 3,348 |
| thrombocytopeniaSignal | 125 | 4.9 | 4.1 | 387 |
| neutropeniaSignal | 147 | 4.7 | 4.1 | 434 |
| decreased appetiteSignal | 194 | 3.7 | 3.2 | 378 |
| vomitingSignal | 327 | 3.1 | 2.8 | 460 |
| urticariaSignal | 113 | 3.0 | 2.5 | 146 |
| rash | 173 | 1.7 | 1.5 | 55 |
| headache | 198 | 1.4 | 1.2 | 22 |
| dizziness | 119 | 1.0 | 0.9 | 0 |
| diarrhoea | 147 | 1.0 | 0.9 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.